{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T11:36:29Z","timestamp":1778326589212,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.3816\/clm.2005.n.026","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:10:42Z","timestamp":1221081042000},"page":"43-45","source":"Crossref","is-referenced-by-count":7,"title":["Activity of Gallium Nitrate in Refractory Peripheral T-Cell Lymphoma"],"prefix":"10.3816","volume":"6","author":[{"given":"ZuoMing","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francine","family":"Foss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2005.n.026_bib1","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1023\/A:1008409601731","article-title":"Therapy with gemcitabine in pretreated peripheral T-cell lymphoma patients","volume":"9","author":"Zinzani","year":"1998","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2005.n.026_bib2","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1182\/blood-2003-10-3389","article-title":"A pilot study of alemtuzumab (anti- CD52 monoclonal antibody) therapy for patients with relapsed or chemotherapy- refractory peripheral T-cell lymphomas","volume":"103","author":"Enblad","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2005.n.026_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1034\/j.1600-0609.2002.00712.x","article-title":"Severe cardiac toxicity after monoclonal antibody therapy","volume":"68","author":"Damaj","year":"2002","journal-title":"Eur J Haematol"},{"key":"10.3816\/CLM.2005.n.026_bib4","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1073\/pnas.68.7.1623","article-title":"Antitumor activity and toxicity of salts of inorganic group 3a metals: aluminum, gallium, indium, and thallium","volume":"68","author":"Hart","year":"1971","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2005.n.026_bib5","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting\u2014Airlie House, Virginia, November 1997","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.026_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","article-title":"Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non- Hodgkin's Lymphoma Classification Project","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"10.3816\/CLM.2005.n.026_bib7","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/S0889-8588(03)00119-9","article-title":"Peripheral T-cell lymphomas: diagnosis and management","volume":"17","author":"Dearden","year":"2003","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.3816\/CLM.2005.n.026_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2141.2001.02743.x","article-title":"Treatment of refractory T-cell malignancies using gemcitabine","volume":"113","author":"Sallah","year":"2001","journal-title":"Br J Haematol"},{"key":"10.3816\/CLM.2005.n.026_bib9","first-page":"1121","article-title":"Toxicity and antitumor activity of gallium nitrate and periodically related metal salts","volume":"47","author":"Hart","year":"1971","journal-title":"J Natl Cancer Inst"},{"key":"10.3816\/CLM.2005.n.026_bib10","first-page":"650","article-title":"Radiogallium localization in tumors: blood binding and transport and the role of transferrin","volume":"21","author":"Vallabhajosula","year":"1980","journal-title":"J Nucl Med"},{"key":"10.3816\/CLM.2005.n.026_bib11","first-page":"103","article-title":"Tumor scanning with 67Ga citrate","volume":"10","author":"Edwards","year":"1969","journal-title":"J Nucl Med"},{"key":"10.3816\/CLM.2005.n.026_bib12","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1172\/JCI112746","article-title":"Effects of different transferrin forms on transferrin receptor expression, iron uptake, and cellular proliferation of human leukemic HL60 cells. Mechanisms responsible for the specific cytotoxicity of transferrin-gallium","volume":"78","author":"Chitambar","year":"1986","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2005.n.026_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.2830410403","article-title":"Treatment with gallium nitrate: evidence for interference with iron metabolism in vivo","volume":"41","author":"Seligman","year":"1992","journal-title":"Am J Hematol"},{"key":"10.3816\/CLM.2005.n.026_bib14","first-page":"3014","article-title":"Effect of gallium on DNA synthesis by human T-cell lymphoblasts","volume":"48","author":"Hedley","year":"1988","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2005.n.026_bib15","first-page":"6199","article-title":"Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells","volume":"51","author":"Chitambar","year":"1991","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2005.n.026_bib16","first-page":"1862","article-title":"Inhibition of protein tyrosine phosphatase by the antitumor agent gallium nitrate","volume":"53","author":"Berggren","year":"1993","journal-title":"Cancer Res"},{"key":"10.3816\/CLM.2005.n.026_bib17","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0300-9084(00)00384-9","article-title":"The effect of gallium nitrate on synoviocyte MMP activity","volume":"82","author":"Panagakos","year":"2000","journal-title":"Biochimie"},{"key":"10.3816\/CLM.2005.n.026_bib18","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00000421-199704000-00015","article-title":"Evaluation of continuous-infusion gallium nitrate and hydroxyurea in combination for the treatment of refractory non-Hodgkin's lymphoma","volume":"20","author":"Chitambar","year":"1997","journal-title":"Am J Clin Oncol"},{"key":"10.3816\/CLM.2005.n.026_bib19","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/1097-0142(19830601)51:11<1982::AID-CNCR2820511104>3.0.CO;2-L","article-title":"Treatment of patients with advanced malignant lymphoma using gallium nitrate administered as a seven-day continuous infusion","volume":"51","author":"Warrell","year":"1983","journal-title":"Cancer"},{"key":"10.3816\/CLM.2005.n.026_bib20","first-page":"47","article-title":"Salvage chemotherapy of advanced lymphoma with investigational drugs: mitoguazone, gallium nitrate, and etoposide","volume":"71","author":"Warrell","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"10.3816\/CLM.2005.n.026_bib21","first-page":"1221","article-title":"Phase II evaluation of bolus gallium nitrate in lymphoproliferative disorders: a Southeastern Cancer Study Group trial","volume":"70","author":"Keller","year":"1986","journal-title":"Cancer Treat Rep"},{"issue":"2 suppl 5","key":"10.3816\/CLM.2005.n.026_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0093-7754(03)00173-8","article-title":"Gallium nitrate in the treatment of lymphoma","volume":"30","author":"Straus","year":"2003","journal-title":"Semin Oncol"}],"container-title":["Clinical Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526965511701166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T17:58:36Z","timestamp":1545760716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526965511701166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S1526965511701166"],"URL":"https:\/\/doi.org\/10.3816\/clm.2005.n.026","relation":{},"ISSN":["1526-9655"],"issn-type":[{"value":"1526-9655","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}